Format

Send to

Choose Destination
Anesthesiol Clin. 2018 Sep;36(3):345-359. doi: 10.1016/j.anclin.2018.04.002. Epub 2018 Jul 11.

Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.

Author information

1
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford School of Medicine, VA Palo Alto Health Care System, 3801 Miranda Avenue (112A), Palo Alto, CA 94304, USA. Electronic address: kyle.harrison@stanford.edu.
2
Pain Fellowship Program, University of California San Francisco School of Medicine, 3 Madrona Avenue, Mill Valley, CA 94941, USA.
3
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford School of Medicine, 450 Broadway, Redwood City, CA 94063, USA.
4
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA; Department of Anesthesiology and Pain Medicine, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA.

Abstract

As part of a national effort to combat the current US opioid epidemic, use of currently Food and Drug Administration-approved drugs for the treatment of opioid use disorder/opioid addiction (buprenorphine, methadone, and naltrexone) is on the rise. To provide optimal pain control and minimize the risk of relapse and overdose, providers need to have an in-depth understanding of how to manage these medications in the perioperative setting. This article reviews key principles and discusses perioperative considerations for patients with opioid use disorder on buprenorphine, methadone, or naltrexone.

KEYWORDS:

Addiction; Buprenorphine; Methadone; Multi modal pain management; Naltrexone; Opioid use disorder; Perioperative; Relapse

PMID:
30092933
DOI:
10.1016/j.anclin.2018.04.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center